GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell?
The Motley Fool
by newsfeedback@fool.com (Robert Izquierdo)February 26, 2026
AI-powered health intelligence firm GeneDx Holdings reported a notable insider sale as it advances its clinical data analytics platform.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/26/2026